Nkarta Therapeutics IPO

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer.

Register for Details

For more details on financing and valuation for Nkarta Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Nkarta Therapeutics's ticker symbol?


What is Nkarta Therapeutics's stock price?

1.62 as of 9/25/23

Learn more about Nkarta Therapeutics

Forge green plus iconForge green minus icon

What is Nkarta Therapeutics funding to date?

Nkarta Therapeutics has raised $125MM to date.
Forge green plus iconForge green minus icon

When was Nkarta Therapeutics founded?

Nkarta Therapeutics was founded in 2015.
Updated on: Jun 12, 2022